Up-regulation of Fas expression by Pseudomonas aeruginosa-infected endothelial cells depends on modulation of iNOS and enhanced production of NO induced by bacterial type III secreted proteins

International Journal of Molecular Medicine

Volumn 18, Issue 2, 2006, Pages 355-363

  Assis, Maria Cristina ^a   Freitas, Carla ^a   Saliba, Alessandra M ^a   Carvalho, Ana Paula D'A ^a   Simao, Tatiana A ^a   Albano, Rodolpho M ^a   Plotkowski, Maria Cristina ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Apoptosis; Fas FasL system; Human umbilical vein endothelial cells; iNOS; NO; P. Aeruginosa; Type III secretion system

Indexed keywords

BACTERIAL PROTEIN; ENZYME INHIBITOR; FAS ANTIGEN; FAS LIGAND; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL; APOPTOSIS; ARTICLE; CELL LINE; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; SECRETION; UPREGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BACTERIAL PROTEINS; CELL LINE; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FAS LIGAND PROTEIN; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; PSEUDOMONAS AERUGINOSA; UP-REGULATION;

EID: 36048941441     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.2.355     Document Type: Article

References (64)

1. Zychlinsky A and Sansonetti PL: Apoptosis in bacterial pathogenesis. Microb Pathog 17: 203-212, 1994.
2. Ayala A, Hemdom C, Lehman D, Ayala CD and Chandry LH: Differential induction of apoptosis in lymphoid tissues during sepsis; variation in onset, frequency, and the nature of the mediators. Blood 87: 4261-4275, 1986.
3. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG and Karl LA: Apoptosis in lymphoid and parenchymal cells during sepsis: findings in norm al and T- and B-cell deficient mice. Crit Care Med 25: 1298-1307, 1997.
4. Grobmyer SR, Armstrong RC, Nicholson SC, Gabay C, Arend WP, Potter SH, Melchior M, Fritz LC and Nathan CF: Peptidomimetic fluoromethylketone rescues mice lethal endotoxic shock. Mol Med 5: 585-594, 1999. (Pubitemid 32936949)
5. Menzies BE and Kourteva L: Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immun 66: 431-439, 1998.
6. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M and Gallily R: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186: 1831-1841, 1997.
7. Valente E, Assis MC, Alvim IMP, Pereira IGMB and Plotkowski MC: Pseudomonas aeruginosa induces apoptosis in human endothelial cells. Microb Pathog 29: 345-356, 2000.
8. Assis MC, Saliba AM, Vidipó LA, Salles J and Plotkowski MC: Pseudomonas aeruginosa-induced production of free radicals by IFNγ plus TNFα-activated endothelial cells: mechanism of host defense or of bacterial pathogenesis? Immunol Cell Biol 82: 383-392, 2004.
9. Buttke TM and Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10, 1994.
10. Jacobson MD: Reactive oxygen species and programmed cell death. Trends Biochem Sci 21: 83-86, 1996. (Pubitemid 26088517)
11. Schulze-Osthoff K: The Fas/APO-1 receptor and its deadly ligand. Trends Cell Biol 4: 421-426, 1994.
12. Henkler F, Behrle E, Dennehy KM, Wicovsky A, Peters N and Warnke C: The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. J Cell Biol 168: 1087-1098, 2005. (Pubitemid 40491178)
13. Grassmé H, Kirschnek S, Riethmueller J, Riehle A, von Kurthy G and Lang F: Host defense to Pseudomonas aeruginosa requires CD95/CD95 ligand interactions on epithelial cells. Science 290: 527-530, 2000.
14. Jendrossek V, Grassmé H, Mueller I, Lang F and Gulbins E: Pseudomonas aeruginosa-induced apoptosis involves mitochondria and stress-activated protein kinases. Infect Immun 69: 2675-2683, 2001.
15. Jendrossek V, Fillon S, Belka C, Muller I, Puttkamme B and Lang F: Apoptotic response of Chang cells to infection with Pseudomonas aeruginosa strains PAK and PAO-I: molecular ordering of the apoptosis signaling cascade and role of type IV pili. Infect Immun 71: 2665-2673, 2003.
16. Cannon CL, Kowalski MP, Stopak KS and Pier GB: Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am J Respir Cell Mol Biol 29: 188-197, 2003.
17. Hueck CJ: Type III protein secretion systems in bacterial pathogens of animals and plants. Mol Biol Rev 62: 379-433, 1998. (Pubitemid 28270280)
18. Hovey AK and Frank DW: Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon. J Bacteriol 177: 4427-4436, 1995.
19. Kudoh I, Wiener-Kronish JP, Hashimoto S, Pittet JF and Frank D: Exoproduct secretions of P. aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol 267: L551-L556, 1994.
20. Fleiszig SMJ, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE and Kanada D: Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 65: 579-586, 1997.
21. Coburn J and Frank DW: Macrophage and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system. Infect Immun 67: 3151-3154, 1999.
22. McGuffie EM, Fraylick JE, Hazen-Martin DJ, Vincent TS and Olson JC: Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S. Infect Immun 67: 3494-3503, 1999.
23. Saliba AM, Filloux A, Ball G, Silva ASV, Assis MC and Plotkowski MC: Type III secretion-mediated killing of endothelial cells by Pseudomonas aeruginosa. Microb Pathog 33: 153-166, 2002.
24. Plotkowski MC, Saliba AM, Pereira SHM, Cervante MP and Bajolet-Laudinat O: Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells. Infect Immun 62: 5456-5463, 1994.
25. Denizot S and Lange R: Rapid colorimetric assay for cell growth and survival. Modification of the tetrazolium dye procedure giving improved sensibility and reliability. J Immunol Methods 89: 271-277, 1986.
26. Suhara T, Fukuo K, Sugimoto T, Morimoto M, Nakahashi T, Hata S, Shimizu M and Ogihara T: Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol 160: 4042-4047, 1998. (Pubitemid 28176114)
27. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen K, Pals ST and van Oers HS: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420, 1994. (Pubitemid 24273007)
28. Bennett M, MacDonald K, Chan SW, Luzio JP, Simari R and Weissberg P: Cell surface trafficking of FasL a rapid mechanism of p53-mediated apoptosis. Science 282: 290-293, 1998.
29. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S and Inoue S: Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182: 1777-1783, 1995.
30. Tanaka M, Itai T, Adachi M and Nagata S: Downregulation of Fas ligand by shedding. Nature Med 4: 31-36, 1998.
31. Silverman DJ and Santucci LA: Potencial for free radical-induced lipid peroxidation as a cause of endothelial cell injury in Rocky Moutain spotted fever. Infect Immun 56: 3110-3115, 1998.
32. Hong Y, Santucci LA, Tian X and Silverman DJ: Superoxide dismutase-dependent, catalase-sensitive peroxides in human endothelial cells infected by Rickettsia rickettsii. Infect Immun 66: 1293-1298, 1998. (Pubitemid 128471482)
33. Mutunga M, Preston PM and Sumption K: Nitric oxide is produced by Cowdria rumunantium infected bovine pulmonary endothelial cells in vitro and is stimulated by gama interferon. Infect Immun 66: 2115-2121, 1998.
34. Moncada S, Palmer RM and Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1990.
35. Esaki T, Hayashim T, Mutuo E, Kano H, Kumar TN and Asai Y: Expression of iNOS and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries. Nitric Oxide Biol Chem 4: 561-571, 2000. (Pubitemid 32053267)
36. Xu W, Liu L and Charles IG: Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J 16: 213-216, 2002.
37. Hauser AR and Engel JN: Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells. Infect Immun 67: 5530-5537, 1999.
38. Bruno TF, Woods DE and Mody CH: Exoenzyme S from Pseudomonas aeruginosa induces apoptosis in T lymphocytes. J Leukoc Biol 67: 808-816, 2000.
39. Kaufman MR, Jinghwa J, Zeng L, Ha U, Chow M and Jin S: Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of ExoS. Microbiol 146: 2531-2541, 2000.
40. Rajani S, Cacalano G, Bryan R, Ratner AJ, Sontich CU and van Heerckeren A: Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells. Am J Respir Cell Mol Biol 23: 304-312, 2000.
41. Jia J, Alaoui-El-Azher M, Chow M, Chambers TC, Baker H and Jin S: c-Jun NH2-terminal kinase-mediated signaling is essential for Pseudomonas aeruginosa ExoS-induced apoptosis. Infect Immun 71: 3361-3370, 2003.
42. Durieu I, Amsellem C, Paulin C, Chambe MT, Bienvenu J, Bellon B and Pacheco Y: Fas and Fas ligand expression in cystic fibrosis airway epithelium. Thorax 54: 1093-1098, 1999.
43. Yamada T, Goto M, Punj V, Zaborina O, das Gupta TK, Kimbara K and Chakrabarty AM: The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect Immun 70: 7054-7062, 2002.
44. Goto M, Yamada T, Kimbara K, Horner J, Newcomb M, GuptaTK and Chakrabarty AM: Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity. Mol Microbiol 47: 549-559, 2003.
45. Dockrell DH: The multiple roles of Fas ligand in the pathogenesis of infectious diseases. Clin Microbiol Infect 9: 766-779, 2003. (Pubitemid 37121078)
46. Yamaoka-Tojo M, Yamaguchi S, Nitobe J, Abe S, Inoue S and Ozaki N: Dual response to Fas ligation in human endothelial cells: apoptosis and induction of chemokines, IL-8 and monocyte chemoattractant protein-1. Coron Artery Dis 14: 89-94, 2003.
47. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A and Tschopp J: Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187: 1205-1213, 1998. (Pubitemid 28189110)
48. Suda TH, Hashimoto M, Tanaka T, Ochi T and Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 186: 2045-2050, 1997. (Pubitemid 28013689)
49. Mogi M, Fukuo K, Yang J, Suhara T and Ogihara T: Hypoxia stimulates release of the soluble form of Fas that inhibits endothelial cell apoptosis. Lab Invest 81: 177-184, 2001. (Pubitemid 32176381)
50. Holler N, Tardivel M, Kovacsovics-Bankowski S, Hertig O, Gaide F and Martinon A: Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 23: 1428-1440, 2003.
51. Blaise GA, Gauvin D, Gangal M and Authier S: Nitric oxide, cell signaling and cell death. Toxicology 208: 177-192, 2005. (Pubitemid 40187330)
52. Aktan F: iNOS-mediated nitric oxide production and its regulation. Life Sci 75: 639-653, 2004. (Pubitemid 38686696)
53. Huang X and Hazlett LD: Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray. Invest Ophthalmol Vis Sci 44: 3409-3416, 2003.
54. Cherayil BJ, McCormick BA and Bosley J: Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2. Infect Immun 68: 5567-5574, 2000.
55. Zharikov SI, Sigova AA, Chen S, Bubb MR and Block ER: Cytoskeletal regulation of the L-arginine NO pathway in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 280: L465-L473, 2001.
56. Su Y, Zharikov SI and Block ER: Microtubule-active agents modify nitric oxide production in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 282: L1183-L1189, 2002.
57. Zeng C and Morrison AR: Disruption of the actin cytoskeleton regulates cytokine-induced iNOS expression. Am J Physiol Cell Physiol 281: C932-C940, 2001.
58. Hattori Y and Kasai K: Disruption of the actin cytoskeleton upregulates iNOS expression in vascular smooth muscle cells. J Cardiovasc Pharmacol 43: 209-213, 2004.
59. Frithz-Lindsten E, Du Y, Rosqvist R and Forsberg A: Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol Microbiol 25: 1125-1139, 1997.
60. Pederson KJ, Vallis AJ, Aktories K, Frank DW and Barbieri JT: The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins. Mol Microbiol 32: 393-401, 1999.
61. Krall R, Schmidt G, Aktories K and Barbieri JT: Pseudomonas aeruginosa ExoT is a Rho GTPasee-activating protein. Infect Immun 68: 6066-6068, 2000.
62. Chang B, Nishikawa M, Sato E and Inoue M: Mice lacking inducible nitric oxide synthase show strong resistance to anti- Fas antibody-induces fulminant hepatitis. Arch Biochem Biphys 411: 63-72, 2003.
63. Niinobu T, Fukuo K, Yasuda O, Tsubakimoto M, Mogi M and Nishimaki H: Negative feedback regulation of activated macrophages via Fas-mediated apoptosis. Am J Physiol Cell Physiol 279: C504-C509, 2000.
64. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y and Tsujimoto Y: Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27: 823-831, 1996.